Ticker brief
IOVA IOVANCE BIOTHERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$14.09
1 day
-0.4%
14 days
-3.6%
mkt cap
$1.9B
signals 14d
21
authors 14d
15
crowd 14d
+0.2σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 117% | IV/HV 1.39× |
| Skew — 25Δ RR 30d | -0.098 | 25Δ call IV − put IV |
| OI alarm | quiet | last alarm 2025-08-08 (z=2.4) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-16 · now -0.35 (−1 bearish … +1 bullish)
Who spoke15
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @RESERVAdeVALOR | C | -1.11 | 3 | +0.17 |
| @equitydd | C | -1.08 | 2 | +0.20 |
| @kunal00 | C | -1.11 | 2 | +0.12 |
| @fundmyfund | B | -0.41 | 2 | +0.47 |
| @bioinvestor24 | A | -0.87 | 2 | +0.57 |
| @StockPatternPro | C | -0.75 | 1 | +0.70 |
| @R1chardMaur1ce | C | -1.19 | 1 | +0.65 |
| @Tickeron | C | +1.53 | 1 | +0.20 |
| @FintwitAi | C | -0.27 | 1 | +0.70 |
| @BiopharmIQ | B | · | 1 | +0.00 |
| @bugra_kurtoglu | C | -0.19 | 1 | +0.70 |
| @tenet_research | C | -1.23 | 1 | +0.70 |
| @HedgeFundTips | B | +0.73 | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | -0.25 |
| @semodough | C | -1.06 | 1 | -0.35 |
Recent signals21of 21 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @semodough | -0.35 | A Cantor survey ranks favorite and least-favorite SMID-cap biotech stocks. | +3.5% | tweet ↗ |
| 2026-10-14 | @OpenOutcrier | -0.25 | Recap lists unusual put activity across multiple names. | -0.8% | tweet ↗ |
| 2026-10-14 | @fundmyfund | +0.50 | Highlights IOVA's strong relative performance during a broad decline. | -0.8% | tweet ↗ |
| 2026-10-13 | @HedgeFundTips | +0.00 | Shares an equal-weight chart of biotech earnings estimates and revisions. | -2.8% | tweet ↗ |
| 2026-10-13 | @tenet_research | +0.70 | Ranks leading 2026 year-to-date stock returns with explicit percentage gains. | -2.8% | tweet ↗ |
| 2026-10-13 | @bugra_kurtoglu | +0.70 | Lists leading one-year US stock returns, capped to the first six named securities. | -2.8% | tweet ↗ |
| 2026-10-11 | @equitydd | +0.10 | Lists the first six stocks in a broad ranking of currently trending names. | -3.6% | tweet ↗ |
| 2026-10-10 | @bioinvestor24 | +0.65 | Questions REPL efficacy and approval quality while praising Iovance's treatment as genuinely life-saving. | -3.6% | tweet ↗ |
| 2026-10-09 | @bioinvestor24 | +0.50 | Notes falling IOVA short interest and argues its resilience forced short covering. | -3.6% | tweet ↗ |
| 2026-10-09 | @kunal00 | +0.25 | Briefly highlights three biotechnology stocks as the day's active theme. | -3.6% | tweet ↗ |
| 2026-10-09 | @fundmyfund | +0.45 | Highlights IOVA's recovery after a sharp healthcare selloff. | -3.6% | tweet ↗ |
| 2026-10-08 | @kunal00 | +0.00 | Describes a volatile index move and presents a multi-ticker watchlist for tomorrow. | +5.9% | tweet ↗ |
| 2026-10-07 | @BiopharmIQ | +0.00 | Lists October clinical-readout timing for multiple biotech companies without directional odds. | +9.1% | tweet ↗ |
| 2026-10-05 | @FintwitAi | +0.70 | Recaps a 129% IOVA rise since an earlier AI flag at $6.21. | -0.4% | tweet ↗ |
| 2026-10-05 | @Tickeron | +0.20 | Lists mid-cap weekly winners and losers; first six winners retained under the ticker cap. | -0.4% | tweet ↗ |
| 2026-10-04 | @R1chardMaur1ce | +0.65 | Recaps an IOVA call rising from $4.14 to $14.22 for a 240% gain. | -0.9% | tweet ↗ |
| 2026-10-04 | @StockPatternPro | +0.70 | Highlights a completed IOVA gain exceeding 350%. | -0.9% | tweet ↗ |
| 2026-10-03 | @RESERVAdeVALOR | +0.00 | Identifies IOVA and cites a weekly chart without a textual directional conclusion. | -0.9% | tweet ↗ |
| 2026-10-03 | @RESERVAdeVALOR | +0.25 | Lists September 2026's top-performing Wall Street equities; ticker list capped at six. | -0.9% | tweet ↗ |
| 2026-10-03 | @RESERVAdeVALOR | +0.25 | Lists the week's top-performing Wall Street equities; ticker list capped at six. | -0.9% | tweet ↗ |
| 2026-10-02 | @equitydd | +0.30 | Lists the leading weekly performers; output is capped at the first six names. | -0.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.